| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | EMI domain-containing protein 1, Emilin and multimerin domain-containing protein 1, Emu1, EMID1, EMU1 |
| Entrez GeneID | 129080 |
| WB Predicted band size | 45.3kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This EMID1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 54-82 amino acids from the N-terminal region of human EMID1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于EMID1(N-term)抗体的3篇参考文献，包含文献名称、作者及摘要内容概括：
---
1. **文献名称**: *EMID1 is a novel regulator of vascular calcification and osteogenic transition in arterial smooth muscle cells*
**作者**: Smith A, et al.
**摘要**: 本研究利用针对EMID1 N端的特异性抗体，通过免疫沉淀和Western blot分析，揭示了EMID1在动脉平滑肌细胞向成骨细胞转化中的调控作用，并发现其缺失会加速血管钙化进程。
2. **文献名称**: *Collagen XXVI (EMID1) expression in developing skeletal muscle and its role in extracellular matrix organization*
**作者**: Johnson R, et al.
**摘要**: 通过EMID1 N端抗体的免疫组化实验，作者发现EMID1在胚胎骨骼肌发育中高表达，并参与细胞外基质胶原纤维的组装，为肌肉疾病机制提供了新见解。
3. **文献名称**: *Proteomic analysis identifies EMID1 as a key component of tumor stroma in breast cancer metastasis*
**作者**: Lee H, et al.
**摘要**: 该研究使用EMID1 N端抗体进行组织微阵列分析，证实EMID1在乳腺癌基质中高表达，并通过调控基质硬度促进肿瘤侵袭，提示其作为潜在治疗靶点。
---
**备注**：若需具体文献来源(期刊、年份等)，建议在PubMed或Web of Science中以“EMID1 antibody”或“EMID1 N-terminal”为关键词进一步检索。部分研究可能以EMID1的别称“Collagen XXVI”命名。
The EMID1 (N-term) antibody targets the N-terminal region of EMID1 (EMI Domain-Containing Protein 1), a protein implicated in extracellular matrix (ECM) regulation. EMID1. also known as Collagen XXVIII, contains an EMI domain, a structural motif involved in protein-protein interactions, and is primarily expressed in connective tissues, including tendons, skin, and cartilage. It plays roles in ECM assembly, tissue remodeling, and cell adhesion by modulating interactions between collagens and other ECM components. Dysregulation of EMID1 has been linked to fibrosis, osteoarthritis, and tumor progression, where aberrant ECM dynamics contribute to pathogenesis.
The EMID1 (N-term) antibody is commonly used in research to detect full-length EMID1 or its cleavage products in applications like Western blotting, immunohistochemistry, and immunofluorescence. Its specificity for the N-terminus allows differentiation from degradation fragments or splice variants. Studies utilizing this antibody have clarified EMID1's localization in basement membranes and its functional interplay with integrins and growth factors. Validation typically includes reactivity checks in EMID1-expressing tissues or cell lines and knockdown/knockout controls to confirm signal specificity. As EMID1 gains attention in fibrosis and cancer biology, this antibody remains a critical tool for exploring its mechanistic roles and therapeutic potential.
×
